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Abstract
Purpose:  Oral  submucous  fibrosis  (OSMF)  is  a  high-risk  precancerous  condition  that 
predominantly affects Indian youngsters due to the habit of gutkha chewing. Candida may 
play a role in the etiopathogenesis of premalignant and malignant lesions. The aim of this 
study is to compare the incidence, intensity, and species of Candida found in OSMF patients 
and healthy individuals. 
Methods: This study included 20 OSMF patients and 20 healthy controls. A detailed history of 
each patient was recorded along with a clinical examination. Samples were collected with the 
oral rinse technique and cultured on Sabouraud’s agar medium. The isolated yeast species were 
counted and identified based on Gram staining, a germ tube test, chlamydospore formation 
and a sugar assimilation test.
Results: In total, 40% of OSMF patients and 15% of healthy controls yielded Candida organisms 
on culture. C. albicans was the predominant species isolated, but C. krusei and C. tropicalis 
were also identified. Gender, gutkha habit and clinical staging had no influence on the candidal 
carriage in OSMF patients. 
Conclusion: The incidence and intensity of Candida (primarily C. albicans) was greater in 
OSMF patients than in healthy controls, but these findings were within the normal limit (3-47%). 
Therefore, Candida may not be an etiologic factor in malignant transformation. However, 
controversy still exists over whether the chewing of betel quid in cases of OSMF has an inhibitory 
effect or promotes the adherence and invasion of Candida.
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Resumo
Objetivo: Fibrose submucosa oral (FSO) é uma condição pré-maligna de alto risco que 
predominantemente afeta jovens da Índia devido ao hábito de mascar ‘gutkha’. Candida pode 
ter um papel importante na etiopatogenia de lesões pré-malignas e malignas. O objetivo deste 
estudo foi comparar a incidência, intensidade e Candida spp encontradas em pacientes com 
FSO e em indivíduos saudáveis. 
Metodologia: Este estudo incluiu 20 pacientes com FSO e 20 controles saudáveis. Obteve-se 
de cada sujeito uma história detalhada e exame clínico. As amostras foram coletadas com 
uma técnica de enxágue bucal e cultivadas em meio Agar Sabouraud. As espécies isoladas 
foram contadas e identificadas com base em coloração Gram, teste de tubo de ensaio e teste 
de assimilação de açúcar. 
Resultados: No total, 40% dos pacientes com FSO e 15% dos controles saudáveis apresentaram 
resultado positivo de cultura para Candida. C. albicans foi a espécie predominante isolada, 
mas C. krusei e C. tropicalis também foram identificados. O sexo, hábito de mascar ‘gutkha’ 
e estadiamento clínico não influenciaram a presença de fungos nos pacientes com FSO. 
Conclusão: A incidência e intensidade de Candida (primariamente C. albicans) foi maior nos 
pacientes com FSO que nos sujeitos controle, mas estes achados estavam dentro dos limites 
normais (3-47%). Portanto, Candida pode não ser um fator etiológico na transformação 
maligna. Entretanto, ainda há controvérsias se o hábito de mascar ‘betel’ em casos de FSO 
teria um efeito inibidor ou promoveria a aderência e invasão de Candida.
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Introduction
Candida species cause common oral fungal infections 
in human beings (1). The presence of Candida in the mouth 
together with epithelial changes may predispose individuals 
to candidal infection (2). Epithelial changes of the oral 
mucosa, such as atrophy, hyperplasia, and dysplasia, may 
compromise the mucosal barrier and facilitate candidal 
invasion, especially in the event of epithelial atrophy (3). 
Candida albicans is the primary cause of oral candidiasis. 
These opportunistic fungal pathogens may colonize, invade 
and induce lesions in any part of the oral cavity in both 
immunocompetent and immunocompromised individuals. 
However, those who are immunocompromised are affected at 
a significantly higher frequency than healthy individuals (4). 
As a result of increasing numbers of immunocompromised 
individuals within the human population, the incidence of 
Candida infections has increased dramatically in the last 
decade (5).
Cannon et al. have suggested that Candida colonization of 
oral surfaces, including the denture-fitting surface, can serve 
as a reservoir for disseminated infections such as aspirate 
pneumonia and gastrointestinal infections (6). C. albicans 
is the predominant species isolated in premalignancy and 
carcinoma. Candidal infection can induce epithelial atypia 
and lead to malignant transformation through the release 
of chemical carcinogens like nitrosamine compounds (2). 
Similarly, Candida could play a role in malignant trans- 
formation in OSMF, but this process has not been confirmed.
Recently, oral submucous fibrosis (OSMF) has been 
identified as a high-risk precancerous condition that affects 
young Indians due to their habit of gutkha chewing (7,8). 
Several predisposing factors may be present in patients 
with  OSMF,  but  epithelial  atrophy  is  considered  one 
of the key features of OSMF. Decreased mouth opening 
may predispose an individual to candidal growth, and this 
Candida can further predispose the mucosa for malignant 
transformation through the process of nitrosation (2,9). The 
aim of the present study was to determine the incidence, 
intensity and species of Candida present in the oral cavity 
of oral submucous fibrosis patients and healthy controls. 
Methods
The  study  included  a  total  of  40  male  and  female 
participants. Patients were selected from among those visiting 
the outpatient department of oral medicine and radiology at 
SDM Dental College and Hospital in Dharwad. The study 
protocol was approved by the institutional ethics committee. 
The study group included twenty cases of oral submucous 
fibrosis and twenty age- and gender-matched healthy controls. 
Informed consent was obtained from all participants prior 
to inclusion in the study. A detailed clinical history was 
obtained from each participant and clinical staging was noted 
using the criteria established by Ranganathan et al. (10). 
OSMF patients with systemic illnesses like diabetes were 
excluded from the study. 
Microbiology
The oral rinse technique described by Samaranayake et 
al. (11) was used to collect samples. Subjects in both groups 
were asked to rinse their mouth with 10 mL of phosphate 
buffered saline (PBS) for 2 min and expectorate into a sterile 
container. The sample was immediately transported to the 
laboratory where it was centrifuged at 2,500 g for 10 min. 
The pellet was resuspended in PBS; 100 μL of this solution 
were plated onto Sabouraud’s dextrose agar and incubated 
for 48 h at 37 °C. Colony forming units resembling yeast 
growth were removed from the plates and processed further 
for identification using Gram staining, a germ tube test, 
chlamydospore formation and sugar assimilation tests (3). 
The number of yeast colonies was counted and expressed as 
colony-forming units per milliliter (CFU/mL) of the collected 
sample. To facilitate the differentiation of C. albicans and 
C. dubliniensis, we investigated the growth at 45 °C on 
modified Sabouraud glucose agar (SGA).
Cytology
Buccal smears were obtained from both groups and 
stained using the periodic acid schiff (PAS) technique. 
The stained smears were examined under a microscope 
(original magnification X40). The presence of Candida yeast 
cells or yeast cells and pseudohyphae was recorded as a 
positive finding and classified as follows: group 1 = none, 
group 2 = yeast cells only, group 3 = a few yeast cells and 
pseudohyphae (2-3 cells), and group 4 = many yeast cells 
and pseudohyphae.
Statistical analysis
Group analyses were performed with the chi-square 
test and the differences between two independent samples 
were analyzed with the Student’s t-test. A P-value<0.05 was 
considered statistically significant.
Results
The mean age of both groups was 26.7 years, and 90% 
of the participants were male. Of the 20 individuals with 
OSMF, 18 (90%) chewed gutkha (areca nut and tobacco) and 
only 2 (10%) chewed areca nut alone. The average mouth 
opening of patients with OSMF was 19.75 mm.
In total, 40% (8/20) of the OSMF patients and 15% 
(3/20) of the controls yielded Candida organisms on culture. 
However, the difference between the two groups was not 
statistically significant (x2=3.135; P=0.770) (Table 1). 
Table  1.  Presence  of  Candida  in  the  OSMF  and  control 
groups.
Groups No. of 
cases
Frequency of 
Candida isolation x2 P-value*
Control Group 20 3 (15%)
3.135 0.077
OSMF Group 20 (40%)
* Chi square test  Rev Odonto Cienc 2011;26(1):71-76  73
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The mean counts of Candida colonies in the OSMF 
and  control  groups  were  721.25  CFU/mL  and  186.7 
CFU/mL, respectively. However, the difference between 
the two groups was not statistically significant (t=5.6030; 
P=0.0053) (Table 2).
Gender had no influence on the yeast carriage in the mouth 
(c2=0.0930, P=0.761) (Fig. 1). The habit of betel chewing 
(Fig. 2) and clinical staging (Fig. 3) had no influence on 
the candidal carriage status of OSMF patients. Cytological 
buccal smears detected no yeast cells or pseudohyphae in 
either group. 
Group Range 
CFU/mL Mean CFU/mL SD t-value P-value*
Control group 60-320 186.6667 130.1281
-5.6030 0.0053
OSMF group 500-970 721.2500 143.8687
* Student’s t-test
Fig. 1. Gender distribution and 
candidal carriage in patients with 
oral submucous fibrosis.
Fig. 2. Chewing habit and 
candidal carriage in patients with 
oral submucous fibrosis. 
Table 2. Intensity of Candida in the 
OSMF and control groups.
Three different candidal species were isolated from 
the OSMF group (C. albicans, C. krusei and C. tropicalis) 
and two species were isolated from the control group (C. 
albicans and C. tropicalis). Candida albicans was the most 
common isolate in OSMF patients (n=7, 87.5%), while 
Candida krusei (37.5%) and Candida tropicalis (12.5%) 
were less common (Fig. 4). In addition, two species were 
simultaneously present in three OSMF patients; C. albicans 
and C. krusei were present in two patients, and C. albicans 
and C. tropicalis were present in one patient.
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Discussion
Healthy individuals carry 3-47% of Candida species as a 
component of normal oral flora (11). Oral yeasts are known 
to be associated with systemic and localized oral disease. 
The predominant species is Candida albicans, which has 
the potential to infect any tissue within the body (6). Other 
Candida species that have been isolated are C. krusei, C. 
guilliermondii and C. tropicalis (12).
An  association  between  Candida  and  various  pre- 
cancerous  and  cancerous  lesions  has  been  reported  in 
the literature (13-15). Candida has also been reported in 
cases of lichen planus, and its prevalence has increased 
in  lichen  planus  patients  undergoing  topical  steroid   
therapy (16).
Studies of various populations have recently linked the 
use of betel quid to the presence of candidal species. Reichart 
et al. has studied oral candidal species in betel quid chewers 
and identified associated oral lesions in Cambodian females. 
Candida albicans was the most commonly isolated species 
and C. tropicalis was the second most isolated species. A 
single isolate of the newly described C. dubliniensis was 
found in the control population (17). 
In another study conducted in isolated populations of 
Padaung, C. parapsilosis was the most common Candida 
species isolated from both betel quid chewers (46%) and 
non-chewers (44%). Candida albicans was identified in 24% 
of betel quid chewers and 18% of non-chewers (18). 
A study by Ariyawardana et al. sought to determine 
the prevalence of oral yeast in OSMF patients and healthy 
individuals.  Candida  was  isolated  from  63.6%  of  the 
test group and 50% of the control group. This study also 
reported C. dubliniensis for the first time in both groups 
(19). However, none of these studies revealed statistically 
significant differences in the prevalence of Candida species 
between the two groups.
Our study revealed a higher candidal prevalence in OSMF 
patients (40%) when compared to a control group (15%), and 
mean scores of candidal growth were also higher in OSMF 
patients than controls; however there was no statistically 
Fig. 3. Clinical staging and 
candidal carriage in patients with 
oral submucous fibrosis.
Fig. 4. Distribution of Candida species  
in OSMF and control group.
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significant difference between the two groups. The results 
of the present study were similar to those presented by 
Ariyawardana et al. (19). In addition, C. albicans was the 
predominant species isolated (87.5%) in OSMF patients 
in this study; other identified species were C. krusei and   
C. tropicalis (Fig. 4). 
We also isolated two species of Candida at the same time 
in 3 of the 20 OSMF patients. Most people carry a single 
strain of Candida at different body sites for a long time. 
For instance C. albicans is most prevalent on the palate, 
tongue and gingiva. However, this study shows that a few 
individuals may harbor more than one strain or species 
of Candida at the same time. This observation suggests 
that several ecological niches exist in the oral cavity that 
harbor different Candida species. However, this occurs 
more commonly in hospitalized and immunocompromised 
patients (14,20). 
In this study, mouth opening was included in the assessment 
of clinical staging, and gutkha was most commonly chewed 
by these patients; gutkha is known to cause early clinical 
symptoms and early malignant transformation (tobacco is 
one component of gutkha). However, this study found no 
correlation between candidal carriage and gender, gutkha 
habit or clinical staging in these OSMF patients. 
In order to proliferate in the oral cavity, yeast cells 
must adhere to oral surfaces; otherwise, they are washed 
away by salivary flows. One of the most important factors 
affecting the virulence of Candida species is therefore their 
ability to use a variety of mechanisms to anchor to a site and 
colonize (20). In betel quid chewers and OSMF patients, the 
constant chewing of betel quid increases the salivary flow 
rate and should lead to the loss of superficial colonization 
and Candida growth. In addition, the hydrophilic solvents 
present in betel quid have inhibitory effects and lead to a 
decreased oral carriage rate of Candida (17). The slaked lime 
content of gutkha creates an alkaline pH in the oral cavity; 
this pH is not favorable for Candida growth because Candida 
is best able to adhere to epithelial cells at an acidic pH. All of 
these factors could explain the low candidal carriage found 
in OSMF and betel quid chewers. Our study therefore shows 
similar results as previous studies. 
In contrast, Reichart et al. reported that the chemical 
constituents of betel quid have no overall effect on the oral 
carriage of Candida and do not preferentially affect the 
specific Candida species present in the oral environment. 
Although betel quid has some antibacterial effects, it does 
not affect oral Candida species (17). 
Oral yeast species carry a significant risk of malignant 
transformation.  There  appears  to  be  a  statistically 
significance relationship between histologically determined 
fungal infection and epithelial dysplasia; about 21.9% of 
candidal infected lesions showed more severe epithelial   
dysplasia  (2,13).  The  possible  association  between   
Candida species and oral neoplasia was first reported in 
the 1960s, and later reports suggested a link between the 
oral mucosal presence of C. albicans and the development 
of oral squamous cell carcinoma (13). Field et al. (1989), 
after reviewing evidence for the role of Candida in oral 
epithelial neoplasia, postulated that nitrosamine compounds 
produced by Candida species may directly, or in concert 
with other chemical carcinogens, activate specific proto-
oncogenes and thus initiate the development of a malignant   
lesion (21). 
Oral submucous fibrosis has a significant mortality rate as 
it is a premalignant condition and malignant transformation 
has been noticed in 2.3-7.6% of cases (22). As the oral 
mucosa is compromised in OSMF, it can be argued that 
the presence of Candida may predispose the individual to 
candidal infection and invasion, although our results were 
not statistically significant. 
OSMF does not regress spontaneously or on cessation 
of gutkha chewing. Once the disease is present, it either 
persists or becomes more severe with the involvement of 
additional areas of the oral mucosa. There is currently no 
successful treatment available for OSMF. Local and systemic 
applications of glucocorticoids and placental extracts and 
the intralesional injection of hyaluronidase (which breaks 
down  the  components  of  connective  tissue)  have  been 
used for OSF therapy (23). Muzyka and Glick surmised 
that corticosteroids lower host resistance to Candida by 
suppressing both nonspecific inflammatory responses and 
cell-mediated immunity (24). Candida colonization that is 
not clinically evident may be easily overlooked, leading to 
ineffective treatment of the underlying lesions. It is therefore 
beneficial to examine the yeast cultures in the oral lesions 
of patients during prolonged steroid therapy. Until now very 
few papers have focused on the prevalence of oral Candida 
in OSMF patients. Therefore the present study made an 
attempt to observe the presence and intensity of Candida 
in OSMF patients.
Conclusions
 A higher incidence and intensity of Candida was observed 
in OSMF patients when compared to healthy individuals, 
but these findings were within normal limits (3-47%). The 
predominant species isolated was C. albicans. Candida 
may not be an etiologic factor in malignant transformation 
in OSMF patients. However, controversy still exists over 
whether betel quid chewing in OSMF inhibits or promotes 
the adherence and invasion of Candida. Further research 
with larger sample sizes is warranted to elucidate the factors 
that may predispose individuals with OSMF to oral candidal 
colonization. Phenotypic characteristics may endow certain 
Candida species or strains with a competitive advantage in 
the oral cavity.76  Rev Odonto Cienc 2011;26(1):71-76
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